Summary
GE HealthCare Technologies Inc. announced a significant leadership change with the appointment of William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Mr. Grogan brings extensive financial leadership experience, most recently serving as CFO of Xylem Inc. and previously as CFO of IDEX Corporation. This appointment marks a transition for the company, with current interim CFO George A. Newcomb returning to his role as Controller and Chief Accounting Officer. Mr. Grogan's compensation package reflects his experience and the incentives designed to attract and retain him, including a substantial base salary, annual bonus targets, and significant long-term equity awards. These awards are structured to align his interests with shareholders, with performance-based and time-based vesting components. The company also provided a cash sign-on payment and an equity award to compensate for forfeited compensation at his previous employer. Investors should monitor the integration of Mr. Grogan into the executive team and his impact on the company's financial strategy and performance.
Key Highlights
- 1William K. Grogan appointed as new Chief Financial Officer, effective September 14, 2026.
- 2George A. Newcomb will transition from interim CFO to Controller and Chief Accounting Officer.
- 3Mr. Grogan has prior CFO experience at Xylem Inc. and IDEX Corporation.
- 4Annual base salary for Mr. Grogan set at $900,000.
- 5Target annual bonus opportunity is 100% of base salary.
- 6Significant long-term incentive awards include a target grant date value of $3,300,000, a one-time sign-on equity award of $4,000,000, and a 2026 annual LTI award of $3,300,000.
- 7Cash sign-on payment of $550,000 and equity awards are intended to compensate for forfeited compensation from his prior employer.